Form 4: Hanover Insurance EVP Lee Receives RSU Grant

Sentiment:

Insider Transaction Report


Hanover Insurance Group's Executive Vice President, Willard T. Lee, acquired 12.247 restricted stock units as dividend equivalent rights under the company's 2022 Long-Term Incentive Plan.

Summary

  • Willard T. Lee, Executive Vice President of Hanover Insurance Group, Inc. (THG), is scheduled to acquire 12.247 shares of Common Stock.
  • The transaction is scheduled for December 26, 2025, and is made pursuant to a Rule 10b5-1 plan.
  • This acquisition represents a grant of restricted stock units (RSUs) under the Issuer's 2022 Long-Term Incentive Plan (2022 LTIP).
  • The RSUs are associated with the accrual of dividend equivalent rights from previously granted RSUs.
  • Following this transaction, Mr. Lee will beneficially own 5,491.951 shares of Common Stock.
  • The RSUs are scheduled to vest on the third anniversary of the date of grant of the original underlying RSUs.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates ongoing executive alignment with shareholder interests through equity compensation, a standard and generally healthy corporate practice. The use of a Rule 10b5-1 plan also adds transparency.

Positives

  • The grant of restricted stock units aligns management's interests with those of shareholders, incentivizing long-term performance.
  • The transaction indicates the ongoing operation of the company's 2022 Long-Term Incentive Plan, a standard practice for executive compensation.
  • The transaction is made pursuant to a Rule 10b5-1 plan, indicating a pre-arranged and transparent trading strategy.

Negatives

  • No specific negative aspects are identified in this routine insider transaction filing.

Risks

  • No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing reports a scheduled acquisition of restricted stock units on December 26, 2025, pursuant to a Rule 10b5-1 plan. These RSUs are scheduled to vest on the third anniversary of the date of grant of the original underlying RSUs, indicating a future equity realization event for the reporting person.

Industry Context

This transaction is a routine insider filing common in publicly traded companies, reflecting executive compensation practices that often include equity awards like restricted stock units to align management incentives with long-term shareholder value. Such grants are a standard component of executive compensation packages in the insurance industry and broader corporate landscape.

Comparison to Industry Standards

  • The grant of restricted stock units (RSUs) as part of an executive compensation plan, particularly for dividend equivalent rights, is a common practice across various industries, including insurance.
  • Companies like Travelers Companies, Inc. (TRV) and Chubb Limited (CB) frequently utilize similar long-term incentive plans involving equity awards for their executives to foster retention and performance alignment.
  • The vesting schedule, typically over several years, is also standard, aiming to encourage long-term commitment and performance.

Stakeholder Impact

  • Shareholders: Benefits from increased alignment of executive interests with long-term company performance.
  • Employees: No direct impact on general employees, but reflects the company's executive compensation structure.

Next Steps

  • The restricted stock units will vest on the third anniversary of the original underlying RSU grant date.

Key Dates

DateDescription
12/26/2025Scheduled date of transaction for the acquisition of restricted stock units pursuant to a Rule 10b5-1 plan.
12/29/2025Date the filing was signed by Lindsay L. Katz pursuant to Confirming Statement.
Third anniversary of original RSU grantVesting date for the acquired restricted stock units.

Recommendation

hold

This Form 4 filing details a routine executive compensation event (RSU grant for dividend equivalents) that is pre-scheduled under a Rule 10b5-1 plan. It does not provide new information that would fundamentally alter the investment thesis for Hanover Insurance Group. It's a standard disclosure that reinforces management's equity stake but doesn't signal a change in company performance or outlook. Therefore, a 'hold' recommendation is appropriate, assuming the investor's existing thesis remains unchanged by this specific filing.

Keywords

Hanover Insurance Group, THG, Willard T. Lee, Restricted Stock Units, RSU Grant, Insider Transaction, Executive Compensation, Form 4, Dividend Equivalent Rights, 2022 LTIP, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.